EASL Video Podcasts

EASL Video Podcasts

By European Association for the Study of the Liver (EASL)Education
Download on the App Store

EASL Video Podcasts episodes

  • EASL Studio Podcast: Rare Liver Malignancies: Small Numbers, Big Questions

    Rare liver tumors like combined HCC/CCA, fibrolamellar HCC, and haemangioendothelioma pose significant diagnostic and therapeutic challenges. In this episode, we explore the latest insights, controversies, and clinical approaches outlined in the new EASL position paper. Join us to uncover how these advancements can address key hurdles in managing these rare malignancies.

    Read the position paper: Rare primary liver cancers: An EASL position paper

    Moderator: Thomas Berg

    Faculty: Ruben de Kleine and Henning Wege

    Related episodes

    • S6E4: World Cholangiocarcinoma Day: Highlighting guidelines and exploring the horizon beyond
    • S5E13: Basics in decision-making for liver cancer treatment
    • S4 Special Edition 1: A new strategy for liver cancer screening: EASL Policy Statement on risk-based surveillance
    • All EASL Studio Podcasts are available on EASL Campus.

      Click here to see all EASL Video Podcasts on Apple Podcasts.

      46 min
    • EASL Studio Podcast: From Evidence to Action: Reducing Alcohol-Related Harm

      This episode of EASL Studio explores insights from the European Alcohol Health Alliance Symposium, hosted by the WHO Regional Office for Europe in collaboration with EASL. Topics include managing alcohol marketing strategies, addressing gaps in cancer-related labelling, and understanding the influence of social norms on adolescent alcohol consumption. Learn from successful alcohol policy implementations and discover how the WHO Playbook can empower advocates to protect children and reshape public health strategies for alcohol-related harm.

      Moderator: Shira Zelber-Sagi

      Faculty: Frank Murray, Catherine Paradis (WHO Europe) and Debbie Shawcross

      Related episodes

      • S7E5 Why does WHO engagement with Steatotic Liver Disease matter?
      • S6E7 The impact of policy measure in preventing liver diseases: The Hepahealth II study
      • EASL Studio live from EASL Congress 2023: The battle to reduce alcohol harms… EASL’s new policy
      • S3E5 JHEP Live: Stigma and alcohol
      • All EASL Studio Podcasts are available on EASL Campus.

        Click here to see all EASL Video Podcasts on Apple Podcasts.

        33 min
      • EASL Studio Podcast: Understanding Sex Disparities in MASLD

        Metabolic dysfunction-associated steatotic liver disease (MASLD) affects men and women differently, yet sex-based differences remain poorly explored. In the week celebrating International Women’s Day, this EASL Studio episode debates the molecular, hormonal, and genetic mechanisms driving these disparities.

        Moderator: Saskia van Mil

        Faculty: Sara Della Torre and Münevver Demir

        Related episode

        • S4E9 YI Choice: Gender equality in academics — reducing the gap
        • All EASL Studio Podcasts are available on EASL Campus.

          Click here to see all EASL Video Podcasts on Apple Podcasts.

          42 min
        • EASL Studio Podcast: Lessons from Your PET: Understanding and Evaluating Treatment for Wilson’s Disease

          Tune into this EASL Studio episode to learn about the role of PET imaging in Wilson’s disease. Discover how PET advances understanding, supports treatment decisions, and enhances patient care in managing this rare liver disorder.

          Moderator: Debbie Shawcross

          Faculty: Aftab Ala, Zoe Mariño and Thomas Sandahl

          This EASL Studio is supported by Orphalan and Univar Solutions.

          EASL has received no input from Orphalan or Univar Solutions with regards to the content of this programme.

          Related episodes

          • S4E15: Diagnostic and therapeutic challenges in Wilson’s disease
          • S4E7: Genetics in adult liver disease – missed opportunities?
          • All EASL Studio Podcasts are available on EASL Campus.

            Click here to see all EASL Video Podcasts on Apple Podcasts.

            40 min
          • EASL Studio Podcast: Liver Cancer Care in 2025: Progress, Hope, and What Lies Ahead

            Join this EASL Studio episode for a clinical perspective on advancing HCC care. Explore the realities of adjuvant therapies, emerging molecular targets, and strategies for curative conversion. Gain insights into practical innovations shaping the future and translating research into improved patient outcomes.

            Moderator: Thomas Berg

            Faculty: Tim Greten and Anna Saborowski

            This EASL Studio is supported by Bayer.

            EASL has received no input from Bayer with regards to the content of this programme.

            Related episodes

            • EASL Studio S5E13: Basics in decision-making for liver cancer treatment
            • EASL Studio from EASL Congress 2023: Highlights of the liver cancer research at EASL Congress 2023
            • EASL Studio S4E16: Highlights from the EASL Liver Cancer Summit 2023
            • EASL Studio S6E9: Therapy hierarchy in HCC: A new kid on the block
            • All EASL Studio Podcasts are available on EASL Campus.

              Click here to see all EASL Video Podcasts on Apple Podcasts.

              46 min
            • EASL Studio Podcast: YI choice: From Idea to Abstract to Publication: Navigating Your Research journey

              Watch this EASL Studio to start navigating your research journey with essential tips on generating ideas, refining hypotheses, and crafting standout abstracts for EASL Congress. Discover how to choose the right journal, prepare a submission-ready manuscript, and boost your career visibility in hepatology.

              Moderator: Thomas Marjot

              Faculty: Marta Afonso, Emma Andersson and Paolo Angeli

              Related episodes

              • S4E20 – COST Actions: Opportunities for pan-European collaborations in liver diseases
              • S4E14 – EASL-EF CLIF and EU Grants: Exploring novel mechanism and treatment of chronic liver failure
              • S4E2 YI Choice – How to build consortia and registries
              • All EASL Studio Podcasts are available on EASL Campus.

                Click here to see all EASL Video Podcasts on Apple Podcasts.

                33 min
              • EASL Studio Podcast: JHEP Live – EASL CPGs on Hepatocellular Carcinoma: What’s New and How Will Practice Change?

                Discover the latest updates from the updated EASL Clinical Practice Guidelines on Hepatocellular Carcinoma (HCC). This episode explores key advancements, their impact on clinical practice, and how they will shape the future of HCC diagnosis, treatment, and management. Join our faculty as they break down the changes and provide practical insights for healthcare professionals.

                Moderator: Thomas Berg

                Faculty: Peter Galle, Josep Llovet and Lorenza Rimassa

                Related episodes

                • EASL Studio S6E4: World Cholangiocarcinoma Day: Highlighting Guidelines and Exploring the Horizon Beyond
                • EASL Studio S6E9: Therapy Hierarchy in HCC: A New Kid on the Block
                • EASL Studio S5E13: Basics in Decision-Making for Liver Cancer Treatment
                • EASL Studio Live from EASL Congress 2024: Advances in Systemic Treatments in Liver Cancer
                • All EASL Studio Podcasts are available on EASL Campus.

                  Click here to see all EASL Video Podcasts on Apple Podcasts.

                  50 min
                • EASL Studio Podcast: 2025 Update on Steatotic Liver Disease: Rethinking Standard of Care

                  Join us for the season premiere of EASL Studio Season 8 as we unpack key insights from the Steatotic Liver Disease (SLD) Summit. Explore the evolving consensus on patient trajectories, advancements in ALD and MetALD treatment pathways, and the latest endpoint discussions. The episode also highlights a holistic approach to diagnosing and managing comorbidities and revisits the standard of care in light of breakthroughs in MASH treatments.

                  Moderator: Aleksander Krag

                  Faculty: Cyrielle Caussy, Sven Francque and Brian Lee

                  This EASL Studio is supported by Madrigal. EASL has received no input from Madrigal with regards to the content of this programme.

                  Related episodes

                  • S7E3 – The changing face of Steatotic Liver Disease: Navigating new opportunities and emerging challenges
                  • EASL Studio at the Congress 2024: SLD nomenclature: Need for refinement?
                  • EASL Studio at the Congress 2024: MASLD anno 2024: A rapidly changing landscape
                  • EASL Studio from EASL Congress 2023 – Steatotic liver disease global consensus to change nomenclature
                  • All EASL Studio Podcasts are available on EASL Campus.

                    Click here to see all EASL Video Podcasts on Apple Podcasts.

                    36 min
                  • EASL DeepDive: Understanding and managing PBC symptoms

                    In this EASL DeepDive held on 03 July 2024, Palak Trivedi, Emma Culver, Andreas Kremer and Jessica Dyson explain the risk assessment in people with PBC as well as the mechanistic and treatment of fatigue and pruritus.

                    Learning objectives

                    • Discover the latest mechanistic insights relating to the occurrence of PBC symptoms
                    • Learn more about the holistic management of PBC symptoms, with a particular emphasis on fatigue and pruritus
                    • Learn more about the current treatment options, their efficacy and limitations
                    • Get a detailed understanding of the drugs in the pipeline for the near future
                    • This EASL DeepDive webinar is supported by GSK and IPSEN. GSK and IPSEN have had no input into the content of this EASL DeepDive.

                      1 hr 16 min
                    • EASL DeepDive: Glucagon in MASH: A next step in “metabolic” drugs tackling liver disease?

                      In this EASL DeepDive held on 30 October 2024, Henning Grønbæk, Cyrielle Caussy, Mazen Noureddin and Frank Tacke provide an understanding of the role of glucagon and glucagon-receptors in physiology and in MASH patients. Additionally, they review key clinical trials and evaluate the integration of GLP-1 receptor agonists into current EASL-EASD-EASO clinical guidelines for practical patient management.

                      Learning objectives:

                      1. Understand the role of glucagon and glucagon-receptor in normal physiology and disease.
                      2. Understand the rationale of a combined dual GLP-1/GCG RA and its potential benefit compared to a GLP-1RA alone and thus gain insights into the mechanisms through which GLP-1 receptor agonists and GLP-1/GCG might affect liver pathology and metabolic regulation.
                      3. Discuss and review key clinical trials and ongoing development programs.
                      4. Evaluate how GLP-1RA can be integrated into current EASL-EASD-EASO CPGs, with a focus on practical applications and patient management strategies, giving potential guidance for future applications.
                      5. This EASL DeepDive webinar is supported by Boehringer Ingelheim. Boehringer Ingelheim has had no input into the content of this EASL DeepDive.

                        1 hr 7 min

                      About EASL Video Podcasts

                      From the publisher's feed

                      The EASL Podcasts in video channel showcases educational episodes derived from the EASL Studio, the EASL DeepDive webinars and the EASL Policy Dialogues. Watch, listen to and stay abreast of the…